Schwerd, Tobias http://orcid.org/0000-0002-2281-4852
Krause, Freia
Twigg, Stephen R. F.
Aschenbrenner, Dominik
Chen, Yin-Huai http://orcid.org/0000-0002-8890-691X
Borgmeyer, Uwe
Müller, Miryam
Manrique, Santiago
Schumacher, Neele
Wall, Steven A.
Jung, Jonathan http://orcid.org/0000-0003-0674-9066
Damm, Timo
Glüer, Claus-Christian
Scheller, Jürgen
Rose-John, Stefan http://orcid.org/0000-0002-7519-3279
Jones, E. Yvonne http://orcid.org/0000-0002-3834-1893
Laurence, Arian
Wilkie, Andrew O. M. http://orcid.org/0000-0002-2972-5481
Schmidt-Arras, Dirk http://orcid.org/0000-0002-1072-7495
Uhlig, Holm H.
Funding for this research was provided by:
Crohn's and Colitis UK
Leona M. and Harry B. Helmsley Charitable Trust
Deutsche Forschungsgemeinschaft (SCHW1730/1-1, SFB841, SFB877, SFB841)
Wellcome Trust (093329)
Exzellenzclusters Entzündungsforschung
RCUK | Medical Research Council (G9900061)
Article History
Received: 29 November 2019
Revised: 11 March 2020
Accepted: 30 March 2020
First Online: 11 June 2020
Competing interests
: No conflict of interest related to this article. H.H.U. has received research support or consultancy fees from UCB Pharma, Eli Lilly, Boehringer Ingelheim, Pfizer, Celgene, MiroBio and AbbVie. H.H.U., A.L., and Y.-H.C are supported by a research collaboration with Celgene.